You just read:

Hematogenix Laboratory Services, LLC (Hematogenix)- Announces the Launch of two U.S. Food and Drug Administration (FDA) Approved PD-L1 Companion Diagnostic Tests to Help Guide Oncologists Using Immuno-Oncology Therapies

News provided by

Hematogenix Laboratory Services, LLC

25 Apr, 2016, 18:37 ET